Entrada Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Related People
Fund Service Providers
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Entrada Therapeutics Inc
CIK #0001689375
EDGAR Form CIK 2011 - 2026
10-K [0001689375]
10-Q [0001689375]
3 [0001689375]
4 [0001689375]
8-K [0001689375]
D [0001689375]
SC 13D [0001689375]
SC 13G [0001689375]
Form 13D/13G Filer Form 13D/13G Subject Filed
TCG Crossover GP I LLC Entrada Therapeutics Inc [2025-11-25]
Janus Henderson Group PLC Entrada Therapeutics Inc [2025-02-14]
BlackRock Inc Entrada Therapeutics Inc [2025-02-04]
Price T Rowe Associates Inc /MD/ Entrada Therapeutics Inc [2022-02-14]
Redmile Group LLC Entrada Therapeutics Inc [2022-02-14]
Roche Finance Ltd Entrada Therapeutics Inc [2022-02-14]
MRL Ventures Fund LLC Entrada Therapeutics Inc [2022-02-08]
Wellington Management Group LLP Entrada Therapeutics Inc [2022-02-04]
Baker Bros Advisors LP Entrada Therapeutics Inc [2021-12-16]
5AM Ventures V LP Entrada Therapeutics Inc [2021-11-12]
MPM BioVentures 2014 LP Entrada Therapeutics Inc [2021-11-12]
Baker Bros Advisors LP Entrada Therapeutics Inc [2021-11-10]
Form 3/4/5 Subject 2011 - 2026
Entrada Therapeutics Inc
Radhakrishnan Maha
Parmar Kush
Kim Peter S
Chapman Gina
Thistle Mary
Zeiher Bernhardt G
Sethuraman Natarajan
Dowden Nathan J
Wentworth KORY James
View All
Terms | Privacy | Providers | Guide
tony@aum13f.com